UROGEN PHARMA: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to UROGEN PHARMA| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↓ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 1 | GOODMAN, CARLLITTLETONCO80122 | SALES REPRESENTATIVEUROGEN PHARMA | ACTBLUEC00401224 | 2024-09-30 | $250 | Primary (P) | EARMARKED FOR HARRIS FOR PRESIDENT (C00703975)Filing 1833806FEC filing ↗ |
| 2 | GOODMAN, CARLCENTENNIALCO80122 | SALES REPRESENTATIVEUROGEN PHARMA | HARRIS FOR PRESIDENTC00703975 | 2024-09-30 | $250 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1833711FEC filing ↗ |
| 3 | GOODMAN, CARLLITTLETONCO80122 | SALES REPRESENTATIVEUROGEN PHARMA | ACTBLUEC00401224 | 2024-11-04 | $250 | Primary (P) | EARMARKED FOR DEMOCRATIC NATIONAL COMMITTEE (C00010603)Filing 1857001FEC filing ↗ |
| 4 | GOODMAN, CARLCENTENNIALCO80122 | SALES REPRESENTATIVEUROGEN PHARMA | DNC SERVICES CORP / DEMOCRATIC NATIONAL COMMITTEEC00010603 | 2024-11-04 | $250 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1858652FEC filing ↗ |
| 5 | SHERTS, TOMMARSPA16046 | EXECUTIVEUROGEN PHARMA | TRUMP NATIONAL COMMITTEE JFC, INC.C00873893 | 2024-11-02 | $104 | Primary (P) | Filing 1858272FEC filing ↗ |
| 6 | SHERTS, TOMMARSPA16046 | EXECUTIVEUROGEN PHARMA | TRUMP NATIONAL COMMITTEE JFC, INC.C00873893 | 2024-11-02 | $104 | Primary (P) | Filing 1858272FEC filing ↗ |
| 7 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2024-10-12 | $25 | Primary (P) | CONTRIBUTION TO ACTBLUEFiling 1841874FEC filing ↗ |
| 8 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2024-09-12 | $25 | Primary (P) | CONTRIBUTION TO ACTBLUEFiling 1833806FEC filing ↗ |
| 9 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | MIKIE SHERRILL FOR CONGRESSC00640003 | 2024-03-10 | $24 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1773259FEC filing ↗ |
| 10 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2023-12-10 | $24 | Not reported | EARMARKED FOR MIKIE SHERRILL FOR CONGRESS (C00640003)Filing 1752852FEC filing ↗ |
| 11 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2023-10-10 | $24 | Not reported | EARMARKED FOR MIKIE SHERRILL FOR CONGRESS (C00640003)Filing 1752852FEC filing ↗ |
| 12 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | MIKIE SHERRILL FOR CONGRESSC00640003 | 2023-12-10 | $24 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1773146 · amendedFEC filing ↗ |
| 13 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2023-08-10 | $24 | Not reported | EARMARKED FOR MIKIE SHERRILL FOR CONGRESS (C00640003)Filing 1752852FEC filing ↗ |
| 14 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | MIKIE SHERRILL FOR CONGRESSC00640003 | 2024-02-10 | $24 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1773259FEC filing ↗ |
| 15 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | MIKIE SHERRILL FOR CONGRESSC00640003 | 2023-10-10 | $24 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1773146 · amendedFEC filing ↗ |
| 16 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2023-07-10 | $24 | Not reported | EARMARKED FOR MIKIE SHERRILL FOR CONGRESS (C00640003)Filing 1752852FEC filing ↗ |
| 17 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | MIKIE SHERRILL FOR CONGRESSC00640003 | 2023-11-10 | $24 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1773146 · amendedFEC filing ↗ |
| 18 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | MIKIE SHERRILL FOR CONGRESSC00640003 | 2024-01-10 | $24 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1773259FEC filing ↗ |
| 19 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2023-11-10 | $24 | Not reported | EARMARKED FOR MIKIE SHERRILL FOR CONGRESS (C00640003)Filing 1752852FEC filing ↗ |
| 20 | MURPHY, POLLYGLEN RIDGENJ07028 | CHIEF BUSINESS OFFICERUROGEN PHARMA | ACTBLUEC00401224 | 2023-09-10 | $24 | Not reported | EARMARKED FOR MIKIE SHERRILL FOR CONGRESS (C00640003)Filing 1752852FEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.